VP, Head of Cell & Genetic Medicines Discovery

MeiraGTx Reports Second Quarter 2025 Financial and Operational Results

Interleukin-23 Inhibitors Market to Surge During the Forecast Period (2025-2034) Due to Demand for Targeted Autoimmune Therapies | DelveInsight

Urothelial Carcinoma Market Set to Expand During the Forecast Period (2025-2034) Amid Rising Incidence and Evolving Therapeutic Landscape | DelveInsight

Johnson & Johnson Innovative Medicine’s Tremfya Gains Momentum in Crohn’s Disease, Outpacing Eli Lilly’s Omvoh and Challenging AbbVie’s Skyrizi

Data Science Co-Op Spring 2026

Johnson & Johnson Innovative Medicine is a leader in healthcare innovation, dedicated to preventing, treating, and curing complex diseases. They are seeking a Data Science Co-Op to support data-driven decision making within the Global Regulatory Affairs organization by driving continuous improvement in data governance, quality, and analytics processes.

Sign up with Google

Sign in with Google